))
DanMandell_e.016
Manage episode 331658528 series 3006114
Contenuto fornito da John Flavin. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da John Flavin o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
e.016 meets Dr. Mandell - a scientist, entrepreneur, and leading expert in synthetic biology, protein engineering, artificial intelligence, and biological and medical informatics. Together with Dr. George Church, he leveraged Genomically Recoded Organisms (GROs) to produce the first proteins with stability and function dependent on non-standard amino acids. Last November Grobio closed a $25 million Series A financing led by Leaps by Bayer and Redmile, a total investment to date of $31.2 million, to help fund the company’s scale-up of bioprocess manufacturing, preclinical validation studies and IND enabling studies.
Dr. Mandell completed his research fellowship in genetics at Harvard Medical School where he was Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. He received his PhD from the University of California, San Francisco, his MSc at University of Edinburgh, and his undergraduate degree in Symbolic Systems from Stanford University.
58 episodi
Condividi
